Spotlight Stories
What Your Doctor Might Not Tell You About Post-Surgery Recovery
After surgical procedures the recovery period represents a critical phase which determines the total success rate of the procedure. Doctors give essential recovery instructions yet important but underemphasized aspects play a major role in healing alongside long-term results. Some key points about post-surgical recovery which doctors typically do not address directly will help you achieve […]

Curated Content

Trending Conversations
Ways the U.S. Healthcare System Lets Patients Down—And How to Push Back
The United States healthcare system operates with major difficulties, which create problems for patients who do not receive adequate service. High healthcare prices function as a significant obstacle that makes Americans avoid necessary medical care because of unaffordable costs. Access to quality healthcare services remains uneven which intensifies healthcare disparities mainly because rural areas experience […]
Between Hope and Hype: The Realities of Experimental Cancer Treatments
Experimental cancer treatments provide hope to patients with aggressive or rare cancers yet they present several unknown factors. Clinical trials demonstrate successful outcomes through their promising results which achieve high success rates in particular patient subgroups. These treatments carry potential dangers to patients due to their side effects and uncertain effectiveness across wider patient populations. […]
Ethics in Medicine: Are Patient Rights Being Respected
The recognition of patient rights depends heavily on medical ethical practices despite existing difficulties. Patients maintain their right to informed consent together with privacy and their freedom to make healthcare decisions. The understanding between healthcare providers and patients about care experiences differs from their actual perceptions. Research indicates that patients consider autonomy important but healthcare […]

Latest Trends

What Your Doctor Might Not Tell You About Post-Surgery Recovery
After surgical procedures the recovery period represents a critical phase which determines the total success rate of the procedure. Doctors give essential recovery instructions yet important but underemphasized aspects play a major role in healing alongside long-term results. Some key points about post-surgical recovery which doctors typically do not address directly will help you achieve a more comfortable path toward your complete health return.
1. The Importance of Mental Health
Surgical recovery requires patients to maintain both physical and mental health improvement. Patients commonly develop depressive or anxious feelings together with frustration during their healing period when their mobility becomes restricted and their recovery time exceeds expectations. Medical professionals concentrate on treating physical conditions yet patients need equal emphasis on mental health care. The combination of mindfulness practices and therapy along with support groups enables patients to handle emotional recovery challenges and develop positive mental perspectives.
2. Nutrition’s Role in Healing
Medical professionals usually provide standard dietary recommendations after surgery but they do not fully emphasize the direct impact of proper nutrition on recovery duration. The combination of protein with vitamins C and D and zinc in your diet helps both tissue healing and strengthens your immune system. Hydration remains essential because water helps remove harmful substances from the body while sustaining all necessary bodily operations. Your recovery time will shorten when you choose whole foods over processed foods as part of your diet.
3. Movement Matters More Than You Think
The need for postoperative rest is vital but too much bed rest leads to complications including blood clots or muscle stiffness. The gentle movements of walking and light stretching help improve blood circulation while reducing swelling which prevents the development of deep vein thrombosis (DVT). Your doctor will probably recommend rest but may not emphasize enough the importance of beginning safe movement activities. The correct exercises for your medical condition must always be approved by your healthcare provider.
4. Sleep Quality Impacts Recovery
The healing process depends heavily on sleep but postoperative pain frequently interrupts restful rest. When sleep quality suffers the body’s tissue repair process becomes slower and the immune system gets weaker. Although doctors typically avoid discussing sleep optimization for recovery they can help patients achieve better sleep by recommending supportive pillows and calm bedtime routines and pre-bedtime pain medication use.
5. Watch for Subtle Signs of Complications
Major complications receive attention when healthcare providers discuss them but subtle issues become apparent only when teams actively monitor patients. Wound dehiscence and delayed healing might manifest through persistent fatigue together with unusual swelling and minor changes in wound appearance. The prevention of minor complications depends on both routine self-checks and immediate medical updates about your symptoms.
6. Avoid Overexertion
After surgery it is common to wish for quick recovery but excessive physical activity leads to problems that delay healing. Doctors typically determine activity return timelines but they do not sufficiently stress the need to adjust your activity pace according to your physical sensations. A slow approach to activity increases allows you to advance steadily without creating opportunities for injuries to occur.
Conclusion
The recovery process extends beyond basic post-operative instructions because it requires active management of physical condition alongside mental state and dietary needs and sleep quality alongside detection of small complications. Your recovery plan will achieve better healing and lasting benefits by including these less common aspects. Your recovery success depends on both discussing your worries with your healthcare provider and participating actively in your recovery process.

Can AI Replace Your Doctor? Patients Weigh in on the Tech Takeover
Numerous debates continue to evolve about artificial intelligence (AI) taking over human medical practitioners in healthcare. Computational systems with artificial intelligence demonstrate outstanding capabilities for handling extensive medical information along with disease recognition abilities and occasionally produce responses showing empathy. Research demonstrates that AI system capability exceeds human doctors by providing effective diagnostic evaluation at equal or better accuracy levels. Patients demonstrate conflicting opinions about this matter. People split in their opinion about AI due to its ability to show precision yet others value human connection in doctor-patient trust relationships.
The integration of AI with medical practice should be seen as an enhancement of doctors’ work by offering better decision support and improved workflow management. Ultimately, the art of healing relies on empathy—a uniquely human trait.

Health Misinformation Online: How Patients Can Find Reliable Answers
Health misinformation found online creates major threats because it weakens trust in vaccines while spreading dangerous methods. Patients can fight misinformation by verifying statements through respected sources that include peer-reviewed studies and government health agencies. The use of sensational language through terms like “miracle cure” or “secret remedy” indicates information that should not be trusted. Patients should base their choices on scientific evidence instead of relying on personal stories and they should verify possible sponsor bias in content they access. WHO platforms advocate reporting false medical claims while users should utilize verified tools to verify information. Patients who remain watchful and knowledgeable about digital health resources can efficiently use correct medical information to make well-informed decisions about their healthcare.
In a digital age where information is just a click away, navigating the sea of health content online can be overwhelming. While the internet offers valuable resources, it also hosts a growing amount of misinformation. By relying on reputable sources such as PatientPOV.org, consulting qualified healthcare professionals, and using critical thinking when evaluating health claims, patients can better protect themselves from false information. Empowering yourself with the right tools and a cautious mindset is key to making informed decisions about your health in the online world.

Ways the U.S. Healthcare System Lets Patients Down—And How to Push Back
The United States healthcare system operates with major difficulties, which create problems for patients who do not receive adequate service. High healthcare prices function as a significant obstacle that makes Americans avoid necessary medical care because of unaffordable costs. Access to quality healthcare services remains uneven which intensifies healthcare disparities mainly because rural areas experience frequent provider shortages. Patients face additional obstacles to necessary treatment because of insurance complexities which include denied claims and restricted coverage. Medical errors that should be prevented and inefficient delivery of care lead patients to experience dissatisfaction along with poor healthcare results.
Patients must fight for full healthcare cost transparency as they work to obtain fair medical care access and support cost reduction reforms that optimize system efficiency.

Between Hope and Hype: The Realities of Experimental Cancer Treatments
Experimental cancer treatments provide hope to patients with aggressive or rare cancers yet they present several unknown factors. Clinical trials demonstrate successful outcomes through their promising results which achieve high success rates in particular patient subgroups. These treatments carry potential dangers to patients due to their side effects and uncertain effectiveness across wider patient populations. The actual treatment results demonstrate substantial differences compared to controlled study conditions.
Patients need to evaluate treatment advantages versus disadvantages by working with healthcare providers to review trial procedures. Experimental treatments show promise but healthcare providers should use caution when deploying them since patients need realistic assessments about survival and life quality expectations.

Ethics in Medicine: Are Patient Rights Being Respected
The recognition of patient rights depends heavily on medical ethical practices despite existing difficulties. Patients maintain their right to informed consent together with privacy and their freedom to make healthcare decisions. The understanding between healthcare providers and patients about care experiences differs from their actual perceptions. Research indicates that patients consider autonomy important but healthcare workers sometimes fail to put it at the forefront of care. Medical facilities must build their programs around ethical education alongside patient-centered services as a solution to this problem. Medical professionals should implement shared decision-making combined with transparency which enhances their ability to protect patient rights. Such an approach both improves patient satisfaction and establishes ethical medical practice standards which deliver effective respectful healthcare.

Nursing Homes for People of Color: Still Segregated, Still Unequal
If Martin Luther King, Jr. was alive today, he would be 86. If he was like many elderly black Americans, he might well end up in a nursing home ranked lower in quality and with less well-trained nursing staff than a nursing home that many white Americans reside in. The facility would likely house a disproportionately larger proportion of people of color and on Medicaid than higher-quality nursing homes.
The disparities are easy to miss. After all, what happens in nursing homes stays in nursing homes, invisible to the rest of us. The only ones who see what’s going on are the patients, family and friends, and staff. If people report lousy conditions in the homes, nursing homes often vilify them. In fact, some would argue that the industry hides behind a smokescreen of patient privacy. Yes, there are inspections. Are they sufficient to drive equal care? Apparently not. Overall, the nursing home industry has changed little in terms of providing quality care for minority elders on par with what white elders get.
Documentation of inequality in long term care for minority elders dates back to enactment of Title VI of the Civil Rights Act and the passage of Medicare in 1966, which prohibited segregation in health facilities that accepted federal funds. In 1981, an Institute of Medicine report addressed the issue of segregated care in nursing homes. The hospital industry was forced to integrate to some degree at least, but nursing homes have been left largely alone.
Contrary to stereotypes, a large Commonwealth Fund analysis led by Vincent Mor, PhD, from the Department of Community Health at Brown University, found that segregation was lowest in the South and highest in the Midwest (Wisconsin, Missouri, Michigan, Indiana, and Ohio). The study found that Cleveland, Ohio, followed closely by Gary, Indiana, were the most segregated cities for nursing homes. Additionally, black elders tended to be in nursing homes in the lowest quarter of quality ratings. Blacks were 1.7 times as likely as white Americans to reside in a nursing home that was subsequently thrown out of the Medicare and Medicaid programs because of poor quality and 2.64 times as likely to be in a facility housing predominantly Medicaid residents. Elderly black Americans are not the only groups at increased risk of going to a poor-quality nursing home. So are elderly Hispanics and probably many other groups not cited here.
The proliferation of for-profit nursing homes in an industry that was once largely nonprofit has also had adverse impacts. In this study, for-profit nursing homes have been found to have lower RN staff intensity and lower RN skill mix than nonprofits, jeopardizing patient care. Poor people on Medicaid are going to for-profit nursing homes at far greater rates in many parts of the country.
This post is a snapshot of one part of long term care, which is an immense, complex topic.
Readers would be misguided if they thought that disparities are concentrated in the Midwest and do not persist elsewhere. These two anecdotes, though not data, are telling. Friends of mine recently watched in tears as a dear African American male friend landed for a long stay in a one-star nursing home in New Jersey. The nursing home housed people of color on Medicaid primarily. My friends were inconsolable when they returned from a visit, quick to call it a “crowded, smelly, dumping ground.” I learned of another story from an older African American woman from Queens NY, a New York City government retiree. I worked with her for many years. When she felt that she could no longer keep up her house, she could not find a satisfactory long term care residence to move into. She never left home: her health deteriorated and eventually, she died at home.
These stark realities are shameful. It’s 2015. We can quibble about statistics, question cause, effect, or association, but outrage, remedies, and stiff penalties and incentives for change are desperately needed.

Are Dense-Breast, Right-to-Know Laws Helpful?
In a victory for the dense-breast patient movement, Governor Jerry Brown (D-CA) signed legislation last week requiring that doctors who discover that women have dense breasts on mammography must inform women that:
- dense breasts are a risk factor for breast cancer;
- mammography sees cancer less well in dense breasts than in normal breasts; and
- women may benefit from additional breast cancer screening.
The California law goes into effect on April 1, 2013. It follows four states (Connecticut, Texas, Virginia, and New York) with similar statutes. All have enjoyed solid bipartisan support. Rarely do naysayers or skeptics speak up about healthcare issues.
Young women who are leading the charge often bring lawmakers the story of a young constituent, diagnosed with a very aggressive, lethal cancer that was not shown on film-screen mammography. The Are You Dense? patient advocacy group engages patients on Facebook, where women share their experiences with breast cancer, organize events, and lobby for legislation. Individual radiologists work with the advocacy groups, but many radiology groups and breast surgeons do not endorse these laws.
A Closer Look at Breast Cancer Data
Living in an age when information is viewed as an entitlement, knowledge, and power, many physicians find it hard to argue against a patient’s right to know. Can sharing information be a mistake? Some epidemiologists think so. Otis W. Brawley, MD, FACP, Chief Medical & Scientific Officer, American Cancer Society, says: “I really worry when we legislate things that no one understands. People can get harmed.” Numerous issues have to be worked out, according to Brawley. For one, he explains: “There is no standard way to define density.” Additionally, “even though studies suggest that density increases the risk of cancer, these cancers tend to be the less serious kind, but even that is open to question,” Brawley says. “We in medicine do not know what to do for women who have increased density.”
A study of more than 9,000 women in the Journal of the National Cancer Institute revealed that women with very dense breasts were no more likely to die than similar patients whose breasts were not as dense. “When tumors are found later in more dense breasts, they are no more aggressive or difficult to treat,” says Karla Kerlikowske, MD, study coauthor, and professor of medicine and epidemiologist at the University of California San Francisco. In fact, an increased risk of death was only found in women with the least dense breasts.
The trouble is what is known about dense breasts is murky. Asked whether he backs advising women that dense breasts are a risk factor for breast cancer, Anthony B. Miller, MD, Co-Chair of the Cancer Risk Management Initiative and a member of the Action Council, Canadian Partnership Against Cancer, and lead investigator of the Canadian National Breast Cancer Screening Study, says: “I would be very cautious. The trouble is people want certainty and chances are whatever we find, all we can do is explain.”
Women in their forties, who are most likely to have dense breasts (density declines with age) may want to seek out digital mammography. In studies comparing digital mammography to film-screen mammography in the same women, digital mammography has been shown to improve breast cancer detection in women with dense breasts. Findings from the Digital Mammographic Imaging Screening Study, showed better breast cancer detection with digital mammography. But digital mammography is not available in many areas. Moreover, Miller explains: “We do not know if this will benefit women at all. It is very probable that removal of the additional small lesions will simply increase anxiety and health costs, including the overdiagnosis of breast cancer, and have no impact upon mortality from breast cancer.”
Additional imaging studies sound attractive to people convinced that there is something clinically significant to find. But as I pointed out in my last post, many radiologists and breast physicians contend that there is no evidence that magnetic resonance imaging or any other imaging study aids breast cancer screening in women with dense breasts. Brawley notes: “These laws will certainly lead to more referral for MRI and ultrasound without clear evidence that women will benefit (lives will be saved.) It’s clear that radiologists will make more money offering more tests.” Miller adds: “A number of doctors are trying to capitalize on this and some of them should know a lot better.”
Many Advocates Question More Tests, Statutes
Even though the “Are You Dense?” campaign has been instrumental in getting legislation on the books across the county, other advocacy groups and patient advocates want research, enhanced patient literacy about risks and benefits of procedures. Many recall mistakes made that led women down the path of aggressive procedures. In that group is the radical Halsted mastectomy, used widely before systematic study, but once studied, found no better than breast-conserving surgery for many cancers, and bone marrow transplants, also found to be ineffective, wearing, and costly.
Jody Schoger, a breast cancer social media activist at @jodyms who engages women weekly on twitter at #bcsm, had this to say on my blog about the onslaught of additional screening tests:
“What is needed is not another expensive modality… but concentrated focus for a biomarker to indicate the women who WILL benefit from additional screening. Because what’s happening now is an avalanche of screening, and its subsequent emotional and financial costs, that is often far out of proportion to both the relative and absolute risk for invasive cancer. I simply don’t think more “external” technology is the answer but one that evolves from the biology of cancer.”
Eve Harris @harriseve, a proponent of patient navigation and patient literacy, challenged Peter Ubel, MD, professor of business administration and medicine, at Duke University, on his view of the value of patient empowerment on the breast density issue. In a post on Forbes, replicated in Psychology Today, Ubel argued that in cases where the pros and cons of a patient’s alternatives are well known, for example, considering mastectomy or lumpectomy, patient empowerment play an important role. “But we are mistaken to turn to patient empowerment to solve dilemmas about how best to screen for cancer in women with dense breasts,” he writes.
Harris disagrees, making a compelling case for patient engagement:
“I think that we can agree that legislative interference with medical practice is not warranted when it cannot provide true consumer protection. But the context is the biggest culprit in this situation. American women’s fear of breast cancer is out of proportion with its incidence and its mortality rate. Truly empowering people—patients would mean improving health literacy and understanding of risk…”
But evidence and literacy take time, don’t make for snappy reading or headlines, and don’t shore up political points. Can we stop the train towards right-to-inform laws and make real headway in women’s health? Can we reallocate healthcare dollars towards effective treatments that serve patients and engage them in their care? You have to wonder.

Is the Bar High Enough for Screening Breast Ultrasounds for Dense Breasts?
If the approval did not take place in the setting of intense pressure to both inform women that they have dense breasts and lobbying to roll out all sorts of imaging studies quickly, no matter how well they have been studied, it would not be worth posting.
Dense breasts are worrisome to women, especially young women (in their 40s particularly) because they have proved a risk factor for developing breast cancer. Doing ultrasound on every woman with dense breasts, though, who has no symptoms, and a normal mammogram potentially encompasses as many as 40% of women undergoing screening mammography who also have dense breasts, according to the FDA’s press release. Dense breast tissue is most common in young women, specifically women in their forties, and breast density declines with age.
The limitations of mammography in seeing through dense breast tissue have been well known for decades and the search has been on for better imaging studies. Government appointed panels have reviewed the issue and mammography for women in their forties has been controversial. What’s new is the “Are You Dense?” patient movement and legislation to inform women that they have dense breasts.
Merits and Pitfalls of Device Approval
The approval of breast ultrasound hinges on a study of 200 women with dense breast evaluated retrospectively at 13 sites across the United States with mammography and ultrasound. The study showed a statistically significant increase in breast cancer detection when ultrasound was used with mammography.
Approval of a device of this nature (noninvasive, already approved in general, but not for this indication) does not require the company to demonstrate that use of the device reduces morbidity or mortality, or that health benefits outweigh risks.
Eitan Amir, MD, PhD, medical oncologist at Princess Margaret Hospital, Toronto, Canada, said: “It’s really not a policy decision. All this is, is notice that if you want to buy the technology, you can.”
That’s clearly an important point, but not one that patients in the US understand. Patients hear “FDA approval” and assume that means a technology most certainly is for them and a necessary add-on. This disconnect in the FDA medical device approval process and in what patients think it means warrants an overhaul or at the minimum, a clarification for the public.
Materials for FDA submission are available on the FDA website, including the study filed with FDA and a PowerPoint presentation, but lots of luck, finding them quickly. “In the submission by Sunnyvale CA uSystems to FDA, the company stated that screening reduces lymph node positive breast cancer,” noted Amir. “There are few data to support this comment.”
Is Cancer Detection A Sufficient Goal?
In the FDA study, more cancers were identified with ultrasound. However, one has to question whether breast cancer detection alone is meaningful in driving use of a technology. In the past year, prostate cancer detection through PSA screening has been attacked because several studies and epidemiologists have found that screening is a poor predictor of who will die from prostate cancer or be bothered by it during their lifetime. We seem to be picking up findings that don’t lead to much to worry about, according to some researchers. Could new imaging studies for breast cancer suffer the same limitation? It is possible.
Another question is whether or not the detected cancers on ultrasound in the FDA study would have been identified shortly thereafter on a routine mammogram. It’s a question that is unclear from the FDA submission, according to Amir.
One of the problems that arises from excess screening is overdiagnosis, overtreatment, and high-cost, unaffordable care. An outcomes analysis of 9,232 women in the US Breast Cancer Surveillance Consortium led by Gretchen L. Gierach, PhD, MPH, at the National Institutes of Health MD, and published online in the August 21 Journal of the National Cancer Institute, revealed: “High mammographic breast density was not associated with risk of death from breast cancer or death from any cause after accounting for other patient and tumor characteristics.” –Gierach et al., 2012
Proposed Breast Cancer Screening Tests
Meanwhile, numerous imaging modalities have been proposed as an adjunct to mammography and as potential replacements for mammography. In 2002, proponents of positron emission tomography (PET) asked Medicare to approve pet scans for imaging dense breast tissue, especially in Asian women. The Medicare Coverage Advisory Commission heard testimony, but in the end, Medicare did not approve it for the dense-breast indication.
PET scans are far less popular today, while magnetic resonance imaging (AKA MR, MRI) and imaging have emerged as as adjuncts to mammography for women with certain risk factors. Like ultrasound, the outcomes data is not in the bag for screening with it.
In an interview with Monica Morrow, MD, Chief of Breast Surgery at Memorial Sloan-Kettering Cancer Center, New York, several months ago concerning the rise in legislation to inform women about dense breasts, which frequently leads to additional imaging studies, she said: “There is no good data that women with dense breasts benefit from additional MR screening.” She is not the only investigator to question potentially deleterious use of MR ahead of data collection and analysis. Many breast researchers have expressed fear that women will opt for double mastectomies, based on MR, that in the end, may have been absolutely unnecessary.
“There is one clear indication for MR screening,” stressed Morrow, explaining that women with BRCA mutations should be screened with MRI. “Outside of that group, there was no evidence that screening women with MR was beneficial.”
At just about every breast cancer meeting in the past two years, the benefits and harms of MR and other proposed screening modalities come up, and there is no consensus in the field. It should be noted, though, that plenty of breast physicians are skeptical about broad use of MR– not just generalists outside of the field. In other words, it is not breast and radiology specialists versus the US Preventive Services Task Force – a very important message for patients to understand.
One thing is clear: as these new technologies gain FDA approval, it will be a windfall for industry. If industry is successful and doctors are biased to promoting these tests, many may offer them on the estimated 40% of women with dense breasts who undergo routine mammograms, as well as other women evaluated as having a high lifetime risk. The tests will be offered in a setting of unclear value and uncertain harms. Even though FDA has not approved breast MRI for screening dense breasts, breast MR is being used off label and it is far more costly than mammography.
When patients raise concerns about the unaffordability of medical care, they should be counseled about the uncertain benefit and potential harms of such a test. That may be a tall bill for most Americans to consider: it’s clear that the more is better philosophy is alive and well. Early detection of something, anything, even something dormant, going nowhere, is preferable to skipping a test, and risking who-knows-what, and that is something, most of us cannot imagine at the outset.

Top 10 Reasons Why Warren Buffett’s Decision to Treat Prostate Cancer Bugs Me
On April 17th, 81-year-old Warren Buffett told investors that he had very early prostate cancer. The Washington Post headline read: “Warren Buffett Has Prostate Cancer that is ”Not Remotely Life Threatening.’” Within hours, news accounts said that the story unfolded after discovering a high PSA in a routine appointment. Next, he had a prostate biopsy. A few hours later, news accounts said that Buffett decided to get radiation therapy for prostate cancer. What’s wrong with this picture?
10. He’s an icon who other men will follow, and there is limited (or no) evidence of benefit of aggressive treatment in men as old as Buffett. At 81, his life expectancy is 7.41 years, shy of the 10-year life expectancy mark doctors look for when they recommend aggressive treatment for prostate cancer.
9. Although Buffett can afford whatever care he so desires, it would cost a fortune if tons of men in his age group went for active treatment and there would be little yield and plenty of side effects.
8. For several years, many physician organizations, including those representing the radiologists and urologists (ASTRO and AUA) who stand to gain income from treating older men, have expressed skepticism about the value of treating and screening men as old as Buffett. That’s because prostate cancer is slow-growing. Buffett is more likely to die from something else.
7. There are far better health care investments that would yield better, long-lasting outcomes. Limited healthcare dollars could be spent on things that actually help people.
6. In some circles, the evidence movement is flourishing and medicine is moving towards more of a scientific base. Yet despite years of intensified effort to base medicine on proof of benefit, or evidence, seemingly has not reached one of America’s smartest men.
5. The war on cancer seems very much alive, no matter what the evidence. Even powerful men, possibly more secure, cannot say no.
4. Buffett may well have side effects from the radiation, namely bowel, urinary incontinence, and impotence.
3. Besides being wasteful, it is not going to save his life.
2. The search for an active surveillance icon continues. I was kind of hoping Buffett could have assumed that role. Surgery has its heroic icons: General Norman Schwarzkopf and Senator Bob Dole. Mayor Rudolph Giuliani went with seeds.
1. If the tide shifts and many more older men choose treatment, it will be a step away from science-based medicine.
A previous version of this post had a different point #1.


Categories
